🇺🇸 FDA
Company

GALECTIN

GALECTIN THERAPEUTICS INC

GALT pharma USA

Quick answer

GALECTIN is a pharma company (GALT) headquartered in NORCROSS, GA, USA with 11 tracked pipeline programs.

Pipeline (11)

project

belapectin

Prevention of Esophageal Varices

Phase 3 · small_molecule · terminated

1 trials project

GM-CT-01

Colorectal Cancer

Phase 2 · small_molecule · terminated

2 trials project

GM-CT-01

Cancer of the Bile Duct

Phase 2 · small_molecule · terminated

1 trials project

GM-CT-01 plus 5-Fluorouracil

Colorectal Cancer

Phase 2 · small_molecule · terminated

1 trials project

GR-MD-02

Psoriasis

Phase 2 · small_molecule · completed

1 trials project

GR-MD-02

Hypertension, Portal

Phase 2 · small_molecule · completed

1 trials project

GR-MD-02

Nonalcoholic Steatohepatitis

Phase 2 · small_molecule · completed

1 trials project

1 mg/kg GR-MD-02

Metastatic Melanoma

Phase 1 · mab · completed

1 trials project

GR-MD-02

Melanoma

Phase 1 · small_molecule · completed

1 trials project

GR-MD-02

Non-Alcoholic Steatohepatitis (NASH)

Phase 1 · small_molecule · completed

1 trials project

belapectin

Hepatic Impairment

Phase 1 · small_molecule · completed

1 trials

Patents (8)

patent

US 12377102

Compounds for the prevention and treatment of medical disorders and uses thereof

Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11583530

Compounds for the prevention and treatment of medical disorders and uses thereof

Expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11576924

Compounds for the prevention and treatment of diseases and the use thereof

Expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11413303

Methods for treatment of arthritis

Expires Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10799525

Composition of novel carbohydrate drug for treatment of human diseases

Expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10744154

Galactose-pronged polysaccharides in a formulation for antifibrotic therapies

Expires Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10420793

Composition of novel carbohydrate drug for treatment of human diseases

Expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9974802

Composition of novel carbohydrate drug for treatment of human diseases

Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)